Tomosyn interacts with the SUMO E3 ligase PIASγ

PLoS One. 2014 Mar 10;9(3):e91697. doi: 10.1371/journal.pone.0091697. eCollection 2014.

Abstract

Protein modification by Small Ubiquitin-like MOdifier (SUMO) entities is involved in a number of neuronal functions, including synaptogenesis and synaptic plasticity. Tomosyn-1 (syntaxin-binding protein 5; STXPB5) binds to t-SNARE (Soluble NSF Attachment Protein Receptor) proteins to regulate neurotransmission and is one of the few neuronal SUMO substrate proteins identified. Here we used yeast two-hybrid screening to show that tomosyn-1 interacts with the SUMO E3 ligase PIASγ (Protein Inhibitor of Activated STAT; PIAS4 or ZMIZ6). This novel interaction involved the C-terminus of tomosyn-1 and the N-terminus of PIASγ. It was confirmed by two-way immunoprecipitation experiments using the full-length proteins expressed in HEK293T cells. Tomosyn-1 was preferentially modified by the SUMO-2/3 isoform. PIASγ-dependent modification of tomosyn-1 with SUMO-2/3 presents a novel mechanism to adapt secretory strength to the dynamic synaptic environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ethylmaleimide / pharmacology
  • HEK293 Cells
  • Humans
  • Male
  • Mice, Inbred BALB C
  • Nerve Tissue Proteins / metabolism*
  • Poly-ADP-Ribose Binding Proteins
  • Protein Binding / drug effects
  • Protein Inhibitors of Activated STAT / metabolism*
  • R-SNARE Proteins / metabolism*
  • Small Ubiquitin-Related Modifier Proteins / metabolism*
  • Two-Hybrid System Techniques
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • Nerve Tissue Proteins
  • PIAS4 protein, human
  • Poly-ADP-Ribose Binding Proteins
  • Protein Inhibitors of Activated STAT
  • R-SNARE Proteins
  • Small Ubiquitin-Related Modifier Proteins
  • tomosyn protein, mouse
  • Ubiquitin-Protein Ligases
  • Ethylmaleimide

Grants and funding

This study was supported by the Centre for Medical Systems Biology [CMSB2 project 3.3.5; http://www.cmsb.nl/research/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.